Particle.news
Download on the App Store

Delani Diekmeier Discharged After First ‘Imaza’ Therapy, Home for Christmas

A second session is planned in six weeks following signs the metastases absorbed the agent.

Overview

  • The 15-year-old left Uniklinik Würzburg after tolerating the initial nuclear-medicine treatment, her mother reported on Instagram.
  • Doctors administered the so-called Imaza therapy, a radiolabeled drug intended to target tumor cells, and Delani was temporarily isolated to limit radiation exposure to others.
  • According to the family, the lung metastases showed uptake of the medication, and they hope to see clinical effects in the coming weeks.
  • The same therapy is scheduled to be repeated in about six weeks in Würzburg.
  • Earlier this year, an adrenal tumor was removed but metastases were found in both lungs, and after a period of palliative classification the family pursued additional treatment options.